Marnetegragene autotemcel (Rocket Pharmaceuticals Inc.) is an investigational gene therapy administered by intravenous infusion for the treatment of severe leukocyte adhesion deficiency-I.
Publications
Hayes Publications are available through the Hayes Knowledge Center, a portal to world-class research and unbiased analyses on the clinical, financial, and risk impacts of emerging, controversial, and disruptive healthcare technologies.Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.
See below for some of our recent publications.
Paradise Ultrasound Renal Denervation System (ReCor Medical Inc.) for Resistant Hypertension
The Paradise Ultrasound Renal Denervation (uRDN) System (ReCor Medical Inc.) uses ultrasound energy delivered via a balloon-cooled catheter to perform targeted circumferential denervation to the renal afferent and efferent sympathetic nerves. The system is indicated to reduce blood pressure as an adjunctive treatment in hypertension patients in whom lifestyle modifications an…
Uterus Transplantation for Treatment of Absolute Uterine Factor Infertility
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of uterus transplantation (UTx) for the treatment of absolute uterine factor infertility (AUFI).
Nuvella System (Neuspera Medical Inc.) for Urinary Urge Incontinence
The Nuvella System (Neuspera Medical Inc.) is an investigational integrated sacral nerve stimulator system for treatment of urinary urge incontinence.
ProSense System (IceCure Medical) for Low-Risk Early-Stage Breast Cancer
The ProSense system (IceCure Medical) is a minimally-invasive, imaging-guided, cryoablation system proposed for treatment of low-risk early-stage breast cancer in patients who are not suitable candidates for surgical alternatives.
Aurora EV-ICD System (Medtronic Inc.) for Ventricular Tachyarrhythmias
The Aurora EV-ICD System (Medtronic Inc.) is an extravascular implantable cardioverter-defibrillator (ICD) indicated for the automated treatment of patients who have experienced, or are at significant risk of developing, life-threatening ventricular tachyarrhythmias through the delivery of antitachycardia pacing, cardioversion, and defibrillation therapies.
Etripamil (Milestone Pharmaceuticals) for Paroxysmal Supraventricular Tachycardia
Etripamil is an investigational, self-administered, calcium-channel blocker, nasal spray for rapid termination of paroxysmal supraventricular tachycardia outside of the healthcare setting.
WiSE Cardiac Resynchronization Therapy System (EBR Systems Inc.)
The WiSE CRT system is a wireless left ventricular pacing system that works with an implanted right ventricular pacemaker and/or defibrillator for patients in whom cardiac resynchronization therapy (CRT) is indicated.
Genicular Artery Embolization With Embozene Microspheres (Varian, a Siemens Healthineers Company) for Symptomatic Knee Osteoarthritis
Embozene Microspheres (Varian, a Siemens Healthineers company) are biocompatible, nonresorbable, hydrogel particles under investigation for genicular artery embolization (GAE) to treat symptomatic knee osteoarthritis (KOA).
Atidarsagene Autotemcel (Orchard Therapeutics) for Metachromatic Leukodystrophy
Atidarsagene autotemcel is an investigational gene therapy administered by intravenous infusion for the treatment of metachromatic leukodystrophy.